PTO- 1478 |
Approved for use through 09/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97050952 |
Filing Date: 09/29/2021 |
Input Field |
Entered |
TEAS Plus | YES |
---|---|
MARK INFORMATION | |
*MARK | CAUTI Prevention |
*STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | CAUTI Prevention |
*MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | CM Technologies Inc |
DBA/AKA/TA/FORMERLY | DBA Consure Medical |
*MAILING ADDRESS | 2165, San Diego Avenue, Suite 101 |
*CITY | San Diego |
*STATE (Required for U.S. applicants) |
California |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
92110 |
PHONE | 800-520-4714 |
*EMAIL ADDRESS | XXXX |
WEBSITE ADDRESS | www.consuremedical.com |
LEGAL ENTITY INFORMATION | |
*TYPE | CORPORATION |
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | California |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
*INTERNATIONAL CLASS | 010 |
*IDENTIFICATION | Medical and surgical catheters |
*FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 06/01/2021 |
FIRST USE IN COMMERCE DATE | At least as early as 06/01/2021 |
SPECIMEN FILE NAME(S) |
\\TICRS\EXPORT18\IMAGEOUT 18\970\509\97050952\xml1 \ FTK0003.JPG |
SPECIMEN DESCRIPTION | Medical products to prevent catheter-associated urinary tract infections, biofilms or urinary tract infections in general. |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
*INTERNATIONAL CLASS | 010 |
*IDENTIFICATION | Medical specimen collection devices in the nature of film, sheath, tube, non-woven, bags for the collection of urine |
*FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 06/01/2021 |
FIRST USE IN COMMERCE DATE | At least as early as 06/01/2021 |
SPECIMEN FILE NAME(S) |
\\TICRS\EXPORT18\IMAGEOUT 18\970\509\97050952\xml1 \ FTK0004.JPG |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
ADDITIONAL STATEMENTS SECTION | |
*TRANSLATION (if applicable) |
|
*TRANSLITERATION (if applicable) |
|
*CLAIMED PRIOR REGISTRATION (if applicable) |
|
*CONSENT (NAME/LIKENESS) (if applicable) |
|
*CONCURRENT USE CLAIM (if applicable) |
|
DISCLAIMER | No claim is made to the exclusive right to use Prevention apart from the mark as shown. |
SIGNIFICANCE OF MARK | CAUTI appearing in the mark means or signifies or is a term of art for Catheter Associated Urinary Tract Infection in the relevant trade or industry or as used in connection with the goods/services listed in the application. |
CORRESPONDENCE INFORMATION | |
NAME | CM Technologies Inc |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | cnagpal@consuremedical.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | info@consuremedical.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Plus |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 250 |
*TOTAL FEES DUE | 250 |
*TOTAL FEES PAID | 250 |
SIGNATURE INFORMATION | |
* SIGNATURE | /CNagpal/ |
* SIGNATORY'S NAME | Charu Nagpal |
* SIGNATORY'S POSITION | Controller |
SIGNATORY'S PHONE NUMBER | 415-260-3083 |
* DATE SIGNED | 09/29/2021 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 09/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97050952 |
Filing Date: 09/29/2021 |
The applicant's current Correspondence Information: |
CM Technologies Inc |
PRIMARY EMAIL FOR CORRESPONDENCE: cnagpal@consuremedical.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): info@consuremedical.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|